bpc 157 injection dose BPC-157 Peptide 10 questions to ask your

Adverse effects observed in trials to date include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (common with GLP-1 receptor agonists) Reduced appetite and weight loss , which may be excessive in some individuals Elevated heart rate , a concern noted with glucagon receptor agonism As with other incretin-based therapies, there is also a class-level signal for acute pancreatitis and gallbladder disease (including cholelithiasis and cholecystitis)

This is printed on the vial label

Hormonal imbalances, metabolism changes, stress, aging, and lifestyle habits can all impact weight loss progress

they look promising for tolerability but have not been compared head-to-head with bisglycinate